References
- Grillo-López AJ. The USA’s healthcare reform: why it will not work. Expert Rev. Anticancer Ther.10(2), 121–122 (2010).
- Grillo-López AJ. The USA’s healthcare reform: challenges and opportunities. Expert Rev. Anticancer Ther.10(3), 295–296 (2010).
- Grillo-López AJ. The ODAC chronicles – part I: my first ODAC experience. Expert Rev. Anticancer Ther.4(5), 579–582 (2004).
- Grillo-López AJ. The ODAC chronicles: part III. The FDA’s philosophy and process for cancer drug evaluation and approval. Expert Rev. Anticancer Ther.5(1), 1–5 (2005).
- Grillo-López AJ. Regulatory process for approval of biologicals for cancer therapy. Book Chapter. In: Principles of Cancer Biotherapy. Fifth Edition. Oldham RK, Dillman RO (Eds). Springer 20, 613–629 (2009).
- Richey EA, Lyons EA, Nebeker JR. Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J. Clin. Oncol.27(26), 4398–4405 (2009).
Websites
- 2008 Annual Report, PHRMA www.phrma.org/index.php?query=annual+report&option=com_swishesearch&intMaxHits=20&intPageOffset=0
- Healthcare in the USA http://en.wikipedia.org/wiki/Health_care_in_the_United_States
- Reference and background material on the FDA can be found at their website www.fda.gov